Wikidata

(Q40183984)

English

Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer

scientific article published on 7 February 2007

In more languages

Statements

title
Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
author name string
David Masiello
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
M Golam Mohi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
Nicole C McKnight
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
Bradley Smith
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
Ben G Neel
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
Steven P Balk
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
Glenn J Bubley
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
publication date
7 February 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017
page(s)
195-201
1 reference
stated in
Europe PubMed Central
PubMed ID
17218776
retrieved
18 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40183984&oldid=1888463859"